Global Electronic Clinical Outcome Assessment (eCOA) for Content Licensed Market is forecasted to grow with significant CAGR owing factor such as growing acceptance of eCOA among clinical research professionals due to efficacy and reliability provided by eCOA solutions.
The adoption of eCOA is being driven by a desire to engage more closely with patients by the pharma industry is accelerating the demand for electronic clinical outcome assessment (eCOA) for content licensed market.
High initial financial costs associated with the implementation and utilization of electronic clinical outcome assessment (eCOA) solutions is a restraining factor for the market.
Electronic clinical outcome assessment (eCOA) for content licensed market has shown an exceptional penetration in countries such as U.S., U.K. and China. Increasing adoption of digitization in clinical trials which aims at performing their end-to-end digital transformation.
Electronic Clinical Outcome Assessment (eCOA) for Content Licensed Market Scenario
According to Data Bridge Market Research, the market for electronic clinical outcome assessment (eCOA) for content licensed market in North America region has the highest market share followed by Europe and Asia-Pacific. Market leader is Oracle which accounts an estimated market share of approximately 15% to 20% in the global electronic clinical outcome assessment (eCOA) for content licensed market. The market is witnessing continuous product launch, partnership and other strategies in the market.
For instance,
- In October 2020, Oracles’ Health Sciences, a division of Oracle specializing in cloud-based life sciences technology is working together with Contract Research organization (CRO) FHI Clinical to create solutions that will boost clinical trial efficiency.
Trends Impacting the Market
Now the question is which other regions Oracle, Parexel International Corporation and ERT Clinical are targeting? Data Bridge Market Research has estimated a large growth in Asia-Pacific electronic clinical outcome assessment (eCOA) for content licensed market and the market leaders targeting China and Japan to be their next revenue pockets for 2021.
The electronic clinical outcome assessment (eCOA) for content licensed market is becoming more competitive every year with companies such as Oracle, Parexel International Corporation and ERT Clinical as they are the market leaders for global electronic clinical outcome assessment (eCOA) for content licensed market. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the electronic clinical outcome assessment (eCOA) for content licensed market.
For more analysis on the electronic clinical outcome assessment (eCOA) for content licensed market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-electronic-clinical-outcome-assessment-ecoa-for-content-licensed-market
Electronic Clinical Outcome Assessment (eCOA) for Content licensed Market Development
- In July 2020, ERT Clinical, a leading company in clinical endpoint data collection has partnered with the leading neuroscience technology company, Cogstate, Ltd. This partnership has enabled ERT to expand its industry-leading electronic Clinical Outcome Assessment (eCOA) solution with digital cognitive endpoint measurement to improve safety and efficacy assessment in clinical trials, including capabilities for at-home testing.
Scope of the Electronic Clinical Outcome Assessment (eCOA) for Content Licensed Market
Global electronic clinical outcome assessment (eCOA) for content licensed market is segmented on the basis of countries into the U.S., Canada, Mexico, Germany, U.K., France, Switzerland, Italy, Spain, Netherlands, Russia, Belgium, Turkey, Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines and Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, UAE, Saudi Arabia, Israel, Egypt and Rest of Middle East & Africa.
- All country based analysis of electronic clinical outcome assessment (eCOA) for content licensed market is further analyzed based on further segmentation. On the basis of product, the electronic clinical outcome assessment (eCOA) for content licensed market is segmented into on-premise solutions, cloud-based solutions and web based solutions. On the basis of approach, the electronic clinical outcome assessment (eCOA) for content licensed market is segmented into clinician reported outcome assessment (ClinRO), patient reported outcome assessment (PRO), observer reported outcome assessment (ObsRO) and performance outcome assessment (PerfO). On the basis of end user, the electronic clinical outcome assessment (eCOA) for content licensed market is segmented into commercial service providers, hospitals and transplant centers and research laboratories and academic institutions. On the basis of platform, the electronic clinical outcome assessment (eCOA) for content licensed market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, medical device manufacturers, consulting service companies, hospitals and clinical laboratories, research and academia and others.
To know more about the study https://www.databridgemarketresearch.com/reports/global-electronic-clinical-outcome-assessment-ecoa-for-content-licensed-market
Key Pointers Covered in Electronic Clinical Outcome Assessment (eCOA) for Content Licensed Market Industry Trends and Forecast to 2028
- Market Size
- Market Standards and Changes
- Market Trials in Different Regions
- Market Requirements in Different Regions
- Market Shares in Different Regions
- Recent Developments for Market Competitors
- Recent Market Value for Different regions
- Sales Data for Market Competitors
- Market Key Vendors and Disruptors Study
Key Market Competitors Covered in the Report
- Oracle
- IBM Corporation
- Dassault Systemes
- Parexel International Corporation
- ERT Clinical
- eClinical Solutions LLC
- ArisGlobal
- Clinical Ink
- Kayentis
- Anju Software, Inc.
- Signant Health
- WIRB-Copernicus Group
- YPrime LLC
- Bioclinica
Above are the key players covered in the report, to know about more and exhaustive list of electronic clinical outcome assessment (eCOA) for content licensed companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-electronic-clinical-outcome-assessment-ecoa-for-content-licensed-market
Research Methodology: Global Electronic Clinical Outcome Assessment (eCOA) for Content Licensed Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand Side: Product Developers, Software Developers, Clinical Researchers, Area Sales Managers, National Sales Managers, and Industrial Professionals among others
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Product Manager and Regulatory Affairs Managers among others.
Related Reports
- Global Clinical Trials Market - Industry Trends and Forecast to 2027
- Global Clinical Trial Imaging Market - Industry Trends and Forecast to 2027
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/
